Cervical Recuperation After Vaginal Delivery
|ClinicalTrials.gov Identifier: NCT03034434|
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : July 27, 2020
|Condition or disease||Intervention/treatment|
|Cervix||Device: Trans-vaginal ultrasound|
Patients after vaginal delivery will be recruited after receiving a full explanation and signing an informed consent.
The goal of the study is to examine cervical length after vaginal delivery at 3 different time intervals:
- 8 hours post delivery.
- 24 hours post delivery.
- 48 hours post delivery. At each interval a trans-vaginal ultrasound will be performed, evaluating cervical length. At the end of the 3rd and final ultrasound, the patient will finish her participation in the study/ Information regarding obstetric conditions such as labor induction, gestational age at the time of delivery etc. will be collected from patients` electronic files.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||1384 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Sonography Evaluation of Cervical Recuperation After Vaginal Delivery|
|Actual Study Start Date :||March 14, 2017|
|Actual Primary Completion Date :||February 29, 2020|
|Actual Study Completion Date :||June 30, 2020|
Patients after vaginal delivery
Patients after vaginal delivery willing to undergo 3 trans-vaginal ultrasounds within the 48 hours after delivery.
Device: Trans-vaginal ultrasound
Three trans-vaginal ultrasounds, the 1st to be performed 8 hours post delivery, the 2nd 24 hours after delivery and the 3rd 48 hours after delivery.
- Cervical length after vaginal delivery. [ Time Frame: Up to 48 hours post delivery. ]Measurement of cervical length 8, 24, 48 hours after vaginal delivery by trans-vaginal ultrasound.
- Differences in cervical length after vaginal delivery. [ Time Frame: Up to 48 hours post delivery. ]Differences in cervical length after vaginal delivery as a factor of gestational age at delivery, means of labor induction, parity, etc.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03034434
|Rambam health care campus|
|Principal Investigator:||Roy Lauterbach, MD||Rambam Health Care Campus|